In primary tumor tissues, positive staining of fibulin 2 was found in 46.2% (24/52) of adenocarcinoma (ADC) and 66.7% (28/42) of squamous cell carcinoma (SCC), and this difference was statistically significant (Figure 1c and Table 1). Here, FBLN2 is linked to adenocarcinoma.